| 2025-07-30 |
DSVFRTM0313588 |
ABBVIE BARCELONETA PR APL ABBVIE |
4528.0 kg |
300490
|
PHARMACEUTICAL PRODUCTS HARMLESSHS CODE 30049000 |
| 2024-12-11 |
BANQ1062948877 |
ABBOTT LABORATORIES S PTE LTD |
19786.0 kg |
300490
|
(PALLETS) WHICH ARE: 35 PALLETS DUPHALAC 1000ML SG 1-00W394-265-S28-154 2 PALLETS ISOPTIN SR 240MG 2X15TAB SG 1-00N046-068-S38-751 HS CODE:30049000 |
| 2024-12-11 |
BANQ1062949055 |
ABBOTT LABORATORIES S PTE LTD |
17805.0 kg |
300420
|
(PALLETS) OF PHARMACEUTICALS WHICH ARE: 27 PALLETS DUPHALAC 200ML SG 1-00W394-266-S28-120 4 PALLETS DUPHALAC 200ML SG 1-00W394-266-S28-120 2 PALLETS KLACID 250MG IR 1X14TAB SG (1-003368-014-S38-014) 3 PALLETS KLACID 500MG MR 1X5TAB SG (1-00M299-041-S38-005) HS CODE:30042000 30049000 |
| 2024-12-03 |
DSVFRTM0291883 |
ABBVIE BARCELONETA PR APL ABBVIE |
4688.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS HARMLESS |
| 2024-11-12 |
BANQ1061620358 |
ABBOTT LABORATORIES S PTE LTD |
21398.0 kg |
300680
|
(PALLETS) PHARMACEUTICALS WHICH ARE: 38 PALLETS |
| 2024-10-04 |
BANQ1060985806 |
ABBOTT LABORATORIES S PTE LTD |
22260.0 kg |
300680
|
(PALLETS) OF PHARMACEUTICALS WHICH ARE: 20 PALLETS |
| 2024-10-04 |
BANQ1060861259 |
ABBOTT LABORATORIES S PTE LTD |
6624.0 kg |
847150
|
(PALLETS) OF PHARMACEUTICALS WHICH ARE: 10 PALLETS DUPHALAC 1000ML SG 1-00W394-265-S28-154 2 PALLETS KLACID 500MG MR 1X7TAB SG (1-00M299-042-S38-007) |
| 2024-10-04 |
BANQ1060859110 |
ABBOTT LABORATORIES S PTE LTD |
22920.0 kg |
300680
|
(PALLETS) OF PHARMACEUTICALS |
| 2024-09-20 |
BANQ1060192502 |
ABBOTT LABORATORIES S PTE LTD |
20281.0 kg |
300680
|
(PALLETS) OF PHARMACEUTICALS WHICH ARE: 36 PALLETS DUPHALAC 200ML SG |
| 2024-09-20 |
BANQ1060494516 |
ABBOTT LABORATORIES S PTE LTD |
22320.0 kg |
300680
|
(PALLETS) PHARMACEUTICALS |
| 2024-09-20 |
BANQ1060494774 |
ABBOTT LABORATORIES S PTE LTD |
9659.0 kg |
300680
|
(PALLETS) PHARMACEUTICALS WHICH ARE: 16 PACKAGES DUPHALAC 200ML SG 1-00W394-266-S28-120 |
| 2024-09-20 |
BANQ1060322556 |
ABBOTT LABORATORIES S PTE LTD |
22320.0 kg |
441520
|
(PALLETS) OF |
| 2024-09-20 |
BANQ1060323361 |
ABBOTT LABORATORIES S PTE LTD |
14407.0 kg |
300680
|
(PALLETS) PHARMACEUTICALS WHICH ARE: 24 PACKAGES DUPHALAC 200ML SG 1-00W394-266-S28-120 4 PACKAGES KLACID 500MG MR 1X5TAB SG |
| 2024-09-20 |
BANQ1060193151 |
ABBOTT LABORATORIES S PTE LTD |
2400.0 kg |
441520
|
(PALLETS) KLACID PED 60ML X |
| 2024-08-23 |
BANQ1060055975 |
ABBOTT LABORATORIES S PTE LTD |
22356.0 kg |
441520
|
(PALLETS) OF |
| 2024-08-23 |
BANQ1060056867 |
ABBOTT LABORATORIES S PTE LTD |
19983.0 kg |
300680
|
(PALLETS) OF PHARMACEUTICALS WHICH ARE: 34 PALLETS DUPHALAC 200ML SG |
| 2024-07-20 |
DSVFRTM0281361 |
ABBVIE BARCELONETA PR APL ABBVIE |
4645.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS HARMLESS |
| 2024-07-12 |
BANQ1060389058 |
TEVA PHARMACEUTICALS USA INC REED |
2584.0 kg |
441520
|
(PALLETS) |
| 2024-05-24 |
DSVFRTM0275883 |
ABBVIE BARCELONETA PR APL ABBVIE |
4670.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS HARMLESS |
| 2024-03-09 |
DSVFRTM0269359 |
ABBVIE BARCELONETA PR APL ABBVIE |
4700.0 kg |
300510
|
PHARMACEUTICAL PRODUCTS HARMLESS |
| 2023-06-17 |
BANQ1052694408 |
ABBVIE INC |
4670.0 kg |
300490
|
CLARITHROMYCIN POWDER HEC V2 CN (3-012385-003-S38-641) ON 21 PALLETS HS CODE:30049000 |
| 2023-04-22 |
BANQ1051754089 |
ABBVIE INC |
4645.0 kg |
300490
|
KGA CLARITHROMYCIN POWDER HEC V2 CN (3-012385-003-S38-641) ON 21 PALLETS HS CODE: 30049000 |